Guizhou Bailing Group Pharmaceutical Co., Ltd. (SHE:002424)
China flag China · Delayed Price · Currency is CNY
5.08
+0.06 (1.20%)
Apr 29, 2026, 3:04 PM CST

SHE:002424 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
6,9345,9385,25511,23611,40410,622
Market Cap Growth
14.16%12.99%-53.23%-1.47%7.37%-3.87%
Enterprise Value
7,9046,9656,93312,72112,73112,179
Last Close Price
5.084.353.858.118.167.60
PE Ratio
--156.31-82.3689.65
Forward PE
-17.7117.7117.7117.7117.71
PS Ratio
2.361.951.372.643.223.41
PB Ratio
2.171.871.643.422.852.74
P/TBV Ratio
2.332.021.783.693.032.92
P/FCF Ratio
14.769.52-519.0326.30-
P/OCF Ratio
11.647.93582.5989.3422.7132.69
EV/Sales Ratio
2.702.291.812.983.603.92
EV/EBITDA Ratio
22.6620.2955.88-38.9638.29
EV/EBIT Ratio
35.5230.66353.32-56.9854.65
EV/FCF Ratio
16.8311.17-587.5929.35-
Debt / Equity Ratio
0.350.390.560.510.390.44
Debt / EBITDA Ratio
3.243.5113.30-4.625.20
Debt / FCF Ratio
2.411.97-77.893.61-
Net Debt / Equity Ratio
0.300.280.440.390.240.32
Net Debt / EBITDA Ratio
2.782.5511.29-4.262.953.93
Net Debt / FCF Ratio
2.031.40-42.4458.592.22-12.39
Asset Turnover
0.450.460.530.600.530.46
Inventory Turnover
1.831.811.461.981.761.58
Quick Ratio
0.670.710.640.731.071.09
Current Ratio
0.950.970.961.061.381.45
Return on Equity (ROE)
-3.12%-3.24%1.14%-11.33%3.46%2.81%
Return on Assets (ROA)
2.14%2.13%0.17%-3.52%2.09%2.06%
Return on Invested Capital (ROIC)
-13.49%-13.39%0.24%-8.46%3.79%3.35%
Return on Capital Employed (ROCE)
6.80%6.70%0.60%-11.20%5.40%5.50%
Earnings Yield
-1.45%-1.76%0.64%-3.69%1.21%1.11%
FCF Yield
6.77%10.50%-0.63%0.19%3.80%-0.95%
Payout Ratio
--241.94%-62.50%84.56%
Buyback Yield / Dilution
18.39%22.40%-21.67%0.22%6.50%-6.92%
Total Shareholder Return
18.39%22.40%-21.67%0.22%6.50%-6.92%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.